VISUAL OUTCOMES AFTER BILATERAL SURGICAL CATARACT PHACOEMULSIFICATION: ACRYSOF® RESTOR IOL IMPLANTATION COMPARED TO MONOFOCAL IOL IMPLANTATION - Alcon RDG-10-269

Alcon Laboratories0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•Ocular criteria must be met in both eyes;
•>= 21 years of age;
•willing and able to attend postoperative examinations as per protocol schedule;
•have bilateral, age-related, cataracts;
•have planned cataract removal via phacoemulsification with implantation of an IOL;
•are available to undergo second eye surgery within 6 weeks of the first eye surgery;
•fulfils the recommendations at the *Warnings* and *Precautions* sections of the AcrySof ReSTOR IOL and Monofocal IOL package inserts;
•have either no pre-operative corneal astigmatism or pre-operative regular corneal astigmatism <=2.5D;
•Both eyes qualify for either AcrySof ReSTOR IOL model SN6AD1 or AcrySof ReSTOR Toric IOLs models SND1T2-SND1T5 on the AcrySof IOL online calculator provide by the sponsor, as described at session 9.2.1 of the protocol 09dec2010.

•If any of the following exclusion criteria are applicable to either eye, the subject shall not be enrolled in the study;
•previous corneal surgery and/or reshaping;
•abnormality, disease and/or conditions of the cornea (i.e. keratoconus, corneal dystrophy, severe keratitis, corneal scar, etc.), which would clinically contra-indicate the implantation of a toric intraocular lens;
•planned multiple procedures during cataract/IOL implantation surgery;
•planned limbal relaxing incision (LRI), Excimer laser treatment or similar procedure prior to or during the course of the study;

发起方

Alcon Laboratories